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For over 20 years, laboratories around the world have been applying the principles of Darwinian evolution to
isolate DNA and RNA molecules with specific ligand-binding or catalytic activities. This area of synthetic
biology, commonly referred to as in vitro genetics, is made possible by the availability of natural polymerases
that can replicate genetic information in the laboratory. Moving beyond natural nucleic acids requires organic
chemistry to synthesize unnatural analogues and polymerase engineering to create enzymes that recognize
artificial substrates. Progress in both of these areas has led to the emerging field of synthetic genetics, which
explores the structural and functional properties of synthetic genetic polymers by in vitro evolution. This
review examines recent advances in the Darwinian evolution of artificial genetic polymers and their potential
downstream applications in exobiology, molecular medicine, and synthetic biology.Merging Chemistry and Biology
In a recent article marking the 40th anniversary of the first in vitro
evolution experiment, Gerald Joyce compared Sol Spiegelman’s
directed evolution of bacteriophage Qb RNA to Friedrich Wo¨h-
ler’s synthesis of urea (Joyce, 2007). Joyce noted that, just as
Wo¨hler’s synthesis of urea broke the false distinction between
biological chemistry and organic synthesis (Wo¨hler, 1828),
Spiegelman’s experiments on Qb RNA broke a similar false
distinction between Darwinian evolution as a biological process
and Darwinian evolution as a chemical process (Mills et al.,
1967). This timely comparison reminds us of the seminal role
that both individuals played in the history of science and how
their pioneering work gave rise to the prodigious fields of organic
chemistry and in vitro genetics (Appella, 2010; Joyce, 2012).
Now, after many decades, these two disciplines are uniting to
form a new field of science called synthetic genetics that aims
to explore the structural and functional properties of synthetic
genetic polymers. Researchers working in this area are devel-
oping in vitro selection systems that allow unnatural genetic
polymers to evolve in response to imposed selection constraints
(Pinheiro et al., 2012; Yu et al., 2012). Previously, the only genetic
polymers capable of undergoing Darwinian evolution were
DNA and RNA, because these were the only molecules with
polymerases available that could replicate, transcribe, and
reverse-transcribe genetic information in the laboratory (Joyce,
2004;Wilson and Szostak, 1999). This paradigm is now changing
as a new generation of polymerases becomes available that can
copy sequence information back and forth between DNA and
XNA. Here, we use the term XNA, sometimes referred to as xen-
onucleic acids, to describe a general class of nucleic acid mole-
cules in which the natural ribose and 20-deoxyribose sugars
found in RNA and DNA have been replaced by an unnatural
moiety (X). While X usually refers to a genetic polymer with an
alternative sugar, nonsugar moieties are also possible, albeit
less common.
Herdewijn and Marlie`re (2009) introduced the term XNA in
a theoretical paper on the development of genetically altered
organisms that use alternative nucleic acid polymers with
backbones that do not interfere with normal DNA and RNA1360 Chemistry & Biology 19, November 21, 2012 ª2012 Elsevier Ltdbiosynthesis. In this review article, we adhere to the traditional
view of XNA as synthetic genetic polymers with unnatural nucleic
acid backbones. We do, however, recognize that the last 2
decades have witnessed tremendous growth in all areas of
nucleic acid chemistry. To date, more than 100 different chemi-
cal modifications have been made to DNA and RNA, and
together, these modifications have improved our understanding
of nucleic acid structure and function. Notable accomplishments
include the following: (1) expansion of the genetic alphabet
beyond the four natural bases of A, C, T, and G (Henry and Ro-
mesberg, 2003; Kool, 2002b; Piccirilli et al., 1990); (2) formation
of Watson-Crick base pairs in the absence of complementary
hydrogen bond donor and acceptor groups (Krueger and Kool,
2007; Lavergne et al., 2012; Mitsui et al., 2003; Moran et al.,
1997); (3) formation of size and strand expanded DNA helices
(Chaput and Switzer, 1999; Kang et al., 2012; Liu et al., 2003);
(4) replication of modified bases using the polymerase chain
reaction (PCR) (Malyshev et al., 2009; Yang et al., 2010); (5)
development of in vitro selection strategies that support modi-
fied bases (Hollenstein et al., 2009a, 2009b; Vaish et al., 2000;
Vaught et al., 2010); and (6) replication and translation of
unnatural codons in living bacteria cells (Delaney et al., 2009;
Krueger et al., 2011). These and many other accomplishments
have profoundly impacted our knowledge of the chemical and
physical properties of DNA and RNA and led to the development
of new sensors, diagnostics, and therapeutic agents for
biotechnology and molecular medicine. Since a thorough
discussion of nucleic acid chemistry is beyond the scope of
this article, we direct readers interested in learning more
about modified nucleic acids and their recognition by DNA and
RNA polymerases to several excellent reviews on this topic
(Appella, 2009; Brudno and Liu, 2009; Kool, 2002a; Zhang
et al., 2010).
In this article, we examine recent advances in the in vitro
evolution of synthetic genetic polymers with novel functional
properties. These developments represent promising new strat-
egies for creating nuclease-resistant molecules that can be
made to function in a variety of natural and unnatural environ-
ments. We begin with a review of molecular evolution and theAll rights reserved
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RNA to synthetic genetic polymers with unnatural nucleic acid
backbones. Next, we discuss examples where in vitro evolution
has been used to isolate XNA molecules with discrete ligand-
binding properties. This discussion covers the complete spec-
trum of XNA polymers from early studies on molecules that
closely resemble natural genetic systems to more diverse back-
bone structures that have begun to explore new regions of
chemical space far beyond the local structural neighborhood
of DNA and RNA. Finally, we conclude with a discussion of
synthetic genetics and the potential impact that this new field
will have on the future of exobiology, molecular medicine, and
synthetic biology. It is our hope that this article will stimulate
others to think about new ways to explore the functional proper-
ties of synthetic genetic polymers and push the field of synthetic
genetics into mainstream molecular biology.
In Vitro Evolution
Darwinian evolution describes how a population changes
overtime to optimize the fitness of individual members for
a particular environment (Darwin, 1859). Evolution is driven by
natural selection, which allows certain inherited traits to become
more or less common as a result of differential survival. Individ-
ualswho adapt to a particular environment pass their genes on to
future generations, while members who are unable to do so go
extinct. Although evolution and natural selection are most often
discussed in terms of living organisms, these concepts can
also be applied to individual molecules (Joyce, 1994; Szostak,
1992). In this regard, genetic polymers are ideally suited for
this purpose, because they can fold into shapes with defined
functional properties (phenotypes) and their sequences (geno-
types) can be replicated in vitro to produce progeny molecules.
The ability to amplify individual molecules with desired pheno-
types and optimize their functions by directed evolution distin-
guishes genetic polymers, like DNA and RNA, from all other
organic molecules, which are incapable of replication because
they lack a genotype-phenotype connection.
To apply the principles of Darwinian evolution to nucleic acids,
a large population of nonidentical sequences is created and this
pool is assayed en masse for individual molecules that can fold
into shapes that can bind to a particular target or catalyze
a specific chemical reaction (Ellington and Szostak, 1990;
Robertson and Joyce, 1990; Tuerk and Gold, 1990). Molecules
with desired phenotypes are separated from the nonfunctional
pool, and their genotypes are amplified to generate a new
population of progeny molecules that has become enriched in
a particular trait. Amplification is usually done at the DNA level
using PCR (Saiki et al., 1985, 1988), but this process can also
be performed at the RNA level by isothermal RNA amplification
(Guatelli et al., 1990). Random mutations that occur during the
amplification process are critical to the selection outcome,
because these genetic changes introduce new diversity into
the sequence population. In general, mutations made to highly
conserved positions tend to have a negative impact on bio-
polymer function, while mutations made to permissive sites
either accumulate as a series of neutral mutations or improve
biopolymer function by correcting suboptimal contacts in the
tertiary structure or by forming new interactions to their substrate
or target ligand (Carothers et al., 2004, 2006). Of course, the realChemistry & Biology 1power of in vitro evolution comes through iterative cycles of
selection and amplification, which makes it possible to search
vast regions of ‘‘sequence space’’ for individual molecules that
arose from one of 1015 different sequences present in the start-
ing population. This level of combinatorial power far surpasses
anything that can be accomplished using even the most sophis-
ticated high throughput screening methods, which is one reason
why in vitro evolution has emerged as a powerful tool in the
biotechnology arsenal.
While in vitro evolution has been used for more than 20 years
to isolate functional DNA and RNAmolecules from large pools of
random sequences (Ellington and Szostak, 1990; Robertson and
Joyce, 1990; Tuerk and Gold, 1990), applying the principles of
Darwinian evolution to artificial genetic polymers remains a chal-
lenging problem. Two major obstacles exist: (1) how to obtain
unnatural nucleic acid substrates that are not commercially
available; and (2) how to identify polymerases that can convert
genetic information back and forth between DNA and XNA.
The first problem can be overcome with organic chemistry;
however, this requires expertise in chemical synthesis or access
to collaborators with knowledge of organic chemistry. Indeed,
the chemical synthesis of modified nucleic acid triphosphates
remains a difficult and labor-intensive process. Nucleoside
triphosphates are not trivial to synthesize or purify, and many
analogs require 10 or more synthetic steps. While these chal-
lenges are not insurmountable, they do represent a significant
bottleneck in the discovery process and one that could slow
the pace at which new genetic polymers are examined. Presum-
ably, this problemwill become less severe over time as the prac-
tical applications of XNA technology motivate chemical and
biotechnology companies to construct these substrates as
commercial products. Until this happens, the focus will remain
on chemistry and the use of chemical synthesis to generate
new types of artificial genetic systems with a diverse repertoire
of chemical functionality.
The second problem is potentially more serious and involves
identifying polymerases that can either copy libraries back and
forth between DNA and XNA or copy XNA directly into XNA
without using DNA as an intermediate. Discovering enzymes
that are suitable for a given XNA system typically involves
screening commercial enzymes, but going forward polymerase
engineering likely will be more important. Unfortunately, natural
polymerases like T7 RNA polymerase and Taq DNA polymerase
rarely accept modified substrates with unnatural backbones.
Even nucleic acid substrates bearing subtle changes to the
ribose or deoxyribose sugar can inhibit these enzymes. This
stringent level of substrate specificity makes it difficult to identify
polymerases that will recognize modified substrates, either as
nucleoside triphosphates or as templates. Fortunately, many
variants of wild-type polymerases have been developed for
DNA sequencing and other biotechnology applications, and
these enzymes are often more permissive of unnatural sub-
strates. Determining which enzymes are best suited for a given
XNA polymer requires screening commercial enzymes in a
primer-extension assay where each polymerase is challenged
to extend a DNA primer annealed to a DNA template with XNA.
Since XNA tends to disrupt critical contacts in the enzyme-
substrate complex, most polymerases terminate primer exten-
sion after one or two nucleotide incorporations. However,9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1361
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Figure 1. Darwinian Evolution of Natural
and Artificial Genetic Systems
Since the discovery of nucleic acid aptamers in the
early 1990s, in vitro selection has been applied to
increasing numbers of RNA and DNA analogs. In
2012, advances in nucleic acid chemistry and
enzyme evolution made it possible to evolve
functional XNA molecules in the laboratory. XNA
molecules are distinct genetic systems with alter-
native (nonribose) nucleic acid backbones.
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these enzymes then become candidates for further optimization.
Optimization can proceed by identifying conditions that allow
the polymerase to function with enhanced efficiency or by
engineering the enzyme itself for improved activity. Both of
these approaches have been used successfully to identify
polymerases that will transcribe and reverse-transcribe XNA
polymers with high efficiency and fidelity (Betz et al., 2012;
Loakes et al., 2009; Pinheiro et al., 2012; Yu et al., 2012).
Certain engineered polymerases are even able to copy limited
stretches of XNA into XNA, suggesting that further polymerase
engineering could lead to DNA independent pathways for XNA
evolution.
Darwinian Evolution of Artificial Genetic Systems
In vitro selection has allowed for the isolation of nucleic acid
sequences that can bind to a wide range of targets from small
molecules to whole cells. In common nucleic acid parlance,
these molecules are referred to as aptamers, which are single-
stranded sequences identified by in vitro evolution that mimic
antibodies by folding into shapes that can bind to a desired
target with high affinity and high specificity (Ellington and
Szostak, 1990). Aptamers represent a valuable class of affinity
reagents as ligand binding can alter or inhibit the biological prop-
erties of their target proteins (Famulok et al., 2007; Keefe et al.,
2010; Mayer, 2009; Nimjee et al., 2005). Unfortunately, genetic
polymers composed of natural DNA or RNA are poor candidates
for diagnostic and therapeutic applications as these molecules
are readily degraded by nucleases—enzymes present in biolog-
ical samples that cleave phosphodiester bonds. Introducing
chemical modifications into the backbone structure that stabilize
the molecule against nuclease degradation can enhance the
potential utility of aptamers as diagnostic and therapeutic
agents. In particular, substitution of the 20 hydroxyl position of
ribonucleotides with amino (NH2), flouro (F), and methoxy
(OCH3) groups confers resistance to nucleases that utilize the
20 hydroxyl group for cleavage of the phosphodiester bond.
Consequently, the first in vitro selection experiments focused
on subtle chemical modifications that were tolerated by natural
polymerases and rendered the aptamer more resistant to
nuclease degradation (Keefe and Cload, 2008). As increasing
numbers of mutant polymerases became available, the field
gradually shifted toward nucleic acid polymers withmore diverse
chemical structures (Figure 1). In the following sections, we
divide our examples into two sections: XNA polymers with back-
bone structures related to RNA and XNA polymers with novel
backbone structures. This distinction is designed to highlight
the progress of different artificial genetic systems and their
contribution to the field of synthetic genetics.1362 Chemistry & Biology 19, November 21, 2012 ª2012 Elsevier LtdXNA Polymers Related to RNA
20 Modified RNA
In 1994, Jayasena and coworkers reported the first example
where Darwinian evolution was applied to pools of modified
genetic polymers (Lin et al., 1994). Using recombinant T7
RNA polymerase, a library of RNA molecules bearing 20-amino-
modified pyrimidines in place of the natural 20 OH group and all
natural purine nucleotides was constructed by in vitro transcrip-
tion (Figure 2). Cell-free transcription gave themodified RNAwith
reduced yield (50%) relative to natural RNA. This library was
used to isolate modified aptamers that bound to human neutro-
phil elastase (HNE) by performing iterative rounds of in vitro
selection and amplification against HNE molecules immobilized
on nitrocellulose filters. HNE is implicated in a number of respira-
tory diseases, including pulmonary emphysema, chronic bron-
chitis, and cystic fibrosis, and as such represents an interesting
therapeutic target. After 15 rounds of in vitro selection and ampli-
fication, amino-modified aptamers were identified that bound to
HNEwith low nanomolar affinity and showed only weak affinity to
porcine pancreatic elastase—a closely related protease. Com-
parative binding assays performed using DNA and RNA mole-
cules with the same nucleotide sequence showed that the
aptamer required the amino modification to achieve high affinity
and high specificity binding. The authors discovered that the
amino-modified aptamer has a half-life of 20 hr in human
serum, which is considerably longer than the serum half-life of
RNA (seconds to minutes, depending on sequence and struc-
ture). While the success of the HNE aptamer provided a clear
demonstration that modified RNA aptamers could be created
by direct selection methods (as opposed to postselection modi-
fication), the amino modification was quickly discarded due to
problems associated with the solid-phase synthesis of amino-
modified RNA and the unpredictable nature of the 20 amino
group (pKa 6.2) at physiological pH.
Recognizing the limitations of 20 amino-modified RNA, other
functional groups were explored as substrates for T7 RNA poly-
merase. Of the possible substitutions, 20 fluoro RNA emerged as
a popular RNA analog (Figure 2). Relative to the 20 amino group,
20 fluoro leads to increased coupling efficiency during solid-
phase synthesis and avoids the need for an additional protection
step when constructed as a phosphoramidite monomer. In addi-
tion, model studies on sequence-defined synthetic oligonucleo-
tides indicate that the 20 fluoro modification enhances the
thermal stability of a duplex (Lesnik et al., 1993), while the 20
amino modification destabilizes the helical structure (Aurup
et al., 1994). The best early example of a 20 fluoro aptamer is
Macugen (pegaptinib sodium), the first therapeutic aptamer
clinically approved by the Food and Drug Administration. Macu-
gen, which is used to treat age-related macular degeneration,All rights reserved
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Figure 2. Examples of Nucleic Acid Analogs
that Closely Resemble DNA and RNA
Nucleic acids with subtle modifications to the
phosphodiester backbone are tolerated to varying
degrees by natural DNA and RNA polymerases.
Each of these examples has been used success-
fully as an unnatural genetic polymer for in vitro
selection.
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lial growth factor (VEGF)-165 to its target receptor. In clinical
trials, 80% of the patients treated with this aptamer show
stable or improved vision 3 months after treatment (Eyetech
Study Group, 2003). Macugen was isolated from a random
sequence RNA library bearing 20-fluoro modified pyrimidines
and natural purine nucleotides (20 OH) (Ruckman et al., 1998).
After the selection, the 28-nucleotide RNA aptamer was
further modified by replacing the 20 OH group at most of
the purine positions with 20-methoxy groups (OCH3) and
appending polyethylene glycol moieties onto the structure
(Ruckman et al., 1998).
The simplicity of the 20 fluoro modification coupled with its
recognition by T7 RNA polymerase have helped make 20 fluoro
RNA a widely used derivative for in vitro selection. More recent
examples of 20-fluoro substituted RNA aptamers include work
by the Rossi and Sullenger labs. In an exciting new development,
Rossi and coworkers evolved 20 fluoro aptamers that bind to HIV
glycoprotein 120 (gp120) with nanomolar affinity (Zhou et al.,
2009). In this study, a commercial T7 RNA polymerase mutant
called DuraScribe T7 RNA polymerase was used due to its
improved ability to incorporate 20-F CTP and 20-F UTP substrates
as well as ATP and GTP. Remarkably, the aptamer is internalized
into HIV-infected cells expressing the HIV envelope protein, sug-
gesting that this aptamer could be used as a drug delivery
system. To test this possibility, the anti-gp120 aptamer was
conjugated with anti-HIV siRNA to form a chimeric aptamer-
siRNA molecule that targets HIV-infected cells and leads to
inhibition of HIV replication and infectivity. In another exciting
development (Mi et al., 2010), the Sullenger lab designed an
in vivo selection method to target tumor-specific moieties. In
this system, an in vivo selection was applied to an animal model
of intrahepatic colorectal cancer metastases by injecting a
nuclease-resistant library of 20 fluoro pyrimidine-modified RNA
into mice bearing previously implanted hepatic tumors. Fol-
lowing an incubation period, the livers were isolated and RNA
molecules from the library were recovered and amplified by
RT-PCR. After multiple cycles of selection and amplification,
an RNA motif emerged that bound to p68 RNA helicase withChemistry & Biology 19, November 21, 2012 ªhigh affinity. This aptamer colocalizes
with p68 and inhibits p68 induced
ATPase activity in tumor cells.
Another promising 20 RNA substitution
often used for the production of thera-
peutic aptamers is 20 methoxy RNA
(OCH3). The 2
0 methoxy substitution
(Figure 2) is a naturally occurring RNA
analog found in ribosomal RNA that arises
via the posttranscriptional machineryinside the cell. While nature has found a way to make this modi-
fication, the incorporation of 20 methoxy residues into growing
RNA strands by in vitro transcription requires mutant versions
of T7 RNA polymerase. Fortunately, several variants of this
enzyme have now been identified that recognize 20-O-methyl
NTPs (Chelliserrykattil and Ellington, 2004; Fa et al., 2004). Using
a modified T7 RNA polymerase bearing the mutations K378R,
Y639F, and H784A, Burmeister et al., reported the first example
of a fully 20-O-methyl-substituted aptamer isolated by in vitro
selection (Burmeister et al., 2005). This unnatural nucleic acid
aptamer binds to VEFG165 with low nanomolar affinity and shows
superior stability in blood with a clearance half-life of 23 hr in
mice models. The same authors used a similar strategy to select
20-O-methyl substituted pyrimidine aptamers that bind to human
thrombin and human interleukin (IL)-23 (Burmeister et al., 2006).
These aptamers also showed high nuclease resistance in model
assays.
Modified Phosphodiester Linkages
Phosphorothioate (PS) oligonucleotides differ from natural oligo-
nucleotides (DNA and RNA) by substitution of a single nonbridg-
ing oxygen atom in the phosphodiester linkage for a sulfur atom
(Figure 2). The markedly lower electronegativity and greater
polarizability of the sulfur atom provides a useful probe for
mechanistic studies involving reactions at the phosphodiester
linkage (Li et al., 2011). This substitution also renders PS oligonu-
cleotides less sensitive to nuclease degradation (Xu and Kool,
1998); hence, this substitution is commonly found in antisense
technology (Dias and Stein, 2002). Nucleoside and deoxynucleo-
side triphosphates bearing sulfur at the a-phosphate position are
recognized by a number of DNA andRNApolymerases, although
their incorporation efficiency varies depending on the enzyme
and the nature of nucleic acid polymer. In a very early example,
Ellington and colleagues showed that fully substituted PS RNA
can be generated by in vitro transcription using standard T7
RNA polymerase and all four (aS) NTPs (Jhaveri et al., 1998).
Enzymatic incorporation of (aS) dNTPs by DNA polymerases
proceeds less efficiently and only oligonucleotides with partial
substitution are possible using standard DNA polymerases.
Recognizing this problem, Holliger and colleagues developed2012 Elsevier Ltd All rights reserved 1363
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cation of fully substituted phosphorothioate DNA polymers up to
2 kb in length (Ghadessy et al., 2004). While thioaptamers have
received broad interest, this backbone substitution is less
common than substitutions made to the 20 ribo-position. One
reason for this could be that PS oligonucleotides are stickymole-
cules that can recognize off-target proteins with nonspecific
binding interactions. Nevertheless, in vitro evolution has pro-
duced thioaptmaers with affinity to a number of proteins,
including molecules that bind to human basic fibroblast growth
factor (Jhaveri et al., 1998), nuclear factor for human IL6 (King
et al., 1998), the RNase H domain of HIV RT (Somasunderam
et al., 2005), the Venezuelan equine encephalitis virus capsid
protein (Kang et al., 2007), and transforming growth factor-b1
(Kang et al., 2008). The thioaptamer selected to bind the RNase
H domain of HIV RT is interesting in that it inhibited RNase H
activity in a dose dependent manner across a broad range of
virus inoculum. At an m.o.i. of < 0.005, viral suppression was
comparable to the HIV drug AZT (Somasunderam et al., 2005).
Another interesting substitution that has been examined by
in vitro evolution is boronophosphate RNA, or bRNA (Figure 2).
Similar to PS RNA, bRNA is constructed using synthetic chem-
istry that replaces the nonbridging oxygen atom in the phospho-
diester linkage with BH3. This substitution, which is isosteric and
isoelectric with respect to the natural phosphodiester linkage
leads to improved nuclease stability (Hall et al., 2004, 2006). In
the context of a DNA backbone, borano-DNA supports RNase
H activity, suggesting a possible role for this modification in
antisense technology (Li et al., 2007). Nucleotide triphosphates
bearing the (aB) NTP substitution are accepted as substrates
by T7 RNA polymerase. bRNA represents an interesting class
of therapeutic aptamers that could find practical application in
an experimental therapy called boron neutron capture therapy
(BNCT) (Hawthorne, 1993). In BNCT, a patient is first injected
with a boron compound that localizes to a cancerous tumor.
The patient is then exposed to neutron irradiation, which causes
the boron compound to emit alpha particles that destroy nearby
cancer cells. In theory, borano-aptamers could function as smart
therapeutics by delivering the boron atom to the cancer cell,
while avoiding healthy cells. In a proof-of-principle demonstra-
tion, Burke and coworkers evolved a series of borano-aptamers
that bound to the small molecule target, adenosine 50-triphos-
phate (ATP) (Lato et al., 2002). ATP is a common target for new
in vitro selection technologies as the ATP-binding RNA aptamer
has a conserved motif that is easy to rediscover by in vitro
selection (Sassanfar and Szostak, 1993). In this case, partially
substituted bRNAwas constructed by in vitro transcription using
T7 RNA polymerase and NTP mixtures containing either (aB)
UTP or (aB) GTP. In addition to identifying the conserved
ATP-binding RNA motif, sometimes referred to as the Sassanfar
aptamer, named after its discoverer Mandana Sassanfar, the
authors found several aptamers whose ligand-binding activity
required the borano modification. This example suggests that
it should be possible to evolve borano-aptamers to other targets
of biological interest.
Mirror Image RNA
Mirror image design provides a clever strategy for generating
stable aptamers with high affinity and specificity for a given
biological molecule. This approach is based on the principle of1364 Chemistry & Biology 19, November 21, 2012 ª2012 Elsevier Ltdreciprocal chiral substrate specificity, which states that polymers
of one stereoconfiguration will exhibit reciprocal chiral substrate
specificity when constructed in the opposite stereoconfigura-
tion. In simple terms, this means that when the L-RNA version
of an RNA aptamer is synthesized, the new L-RNA aptamer will
bind the mirror image of the target (Figure 2). Thus, using mirror
image symmetry, L-RNA aptamers can be generated by carrying
out in vitro selection experiments against the mirror image of
natural biological targets. Fu¨rste and colleagues first demon-
strated this principle by identifying RNA sequences that could
bind to L-adenosine and D-arginine (the enantiomers of the
natural D-adenosine and L-arginine metabolites) (Klussmann
et al., 1996; Nolte et al., 1996). Nucleic acid sequences present
in the selection output were constructed by solid-phase
synthesis as both L- and D-RNA. The sequences constructed
of L-RNAwere given the name ‘‘spiegelmers’’—from theGerman
word ‘‘spiegel,’’ meaning mirror—to distinguish them from the
traditional D-RNA aptamers. Functional analysis studies re-
vealed that spiegelmers and aptamers with the same sequence
have identical binding affinity but reciprocal binding specificity.
In this case, spiegelmers recognized the natural metabolites to
the near exclusion of the unnatural enantiomers, while the
aptamers exhibited the opposite binding pattern and bound
the unnatural D-adenosine and L-arginine metabolites. Because
L-RNA is an unnatural nucleic acid backbone, the evolved
spiegelmers remain stable in human serum after 60 hr, while
the natural RNA aptamers rapidly degrade.
The ability for spiegelmers to withstand nuclease degradation
suggests that these molecules could have potential therapeutic
value. The first biological assay involving a spiegelmer was re-
ported in 1997 by Kim and Bartel (Williams et al., 1997). Here,
a spiegelmer to the peptide hormone L-vasopressin was pro-
duced using the unnatural D-peptide analog as bait. After several
rounds of in vitro selection and amplification followed by directed
evolution, a spiegelmer was generated that binds to vaso-
pressin. This molecule was shown to antagonize the vasopressin
response in cultured kidney cells. Similar studies have since
been performed on other pharmacological targets, including
the peptide hormone gonadotropin-releasing hormone I
(GnRH) (Leva et al., 2002). Spiegelmers generated to GnRH
were shown to inhibit GnRH binding to its cognate receptor in
Chinese hamster ovary cells with half maximal inhibitory concen-
tration (IC50) values of 50–200 nM. While the concept of mirror
image design provides a convenient strategy for generating
nuclease-resistant ligands, the requirement for mirror image
targets limits this approach to small molecules and short
proteins that are accessible by chemical synthesis. Recognizing
this problem, Klussmann and colleagues developed a domain-
based approach in which the peptide segment of a surface-
accessible domain was used as a target in place of the whole
protein (Purschke et al., 2003). In this case, the spiegelmer,
which was selected to bind a 25-amino-acid segment of
staphylococcal Enterotoxin B, exhibited nanomolar affinity to
the full-length protein.
Joyce and colleagues recently extended the concept of mirror
image symmetry to include catalytic RNA (Olea et al., 2012). In
this case, a self-replicating all L-RNA enzyme and its all L-RNA
substrate were prepared by solid-phase synthesis from L-nucle-
oside phosphoramidites. The whole system was based onAll rights reserved
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HNA and TNA are XNA systems in which the natural ribose sugar found in RNA
has been replaced with a nonribose sugar moiety. HNA and TNA require
engineered polymerases for their replication. PNA is a nucleic acid system
based on repeating amide bonds that replicates by nonenzymatic template-
directed polymerization.
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for ligand sensing but was limited in its application due to its
susceptibility to ribonuclease degradation. The L-ribozyme
was shown to undergo isothermal, theophylline-dependent
exponential amplification, in a manner analogous to the natural
RNA ribozyme system. However, unlike the RNA ribozyme, the
L-RNA system was impervious to nuclease degradation. This
demonstration suggests that it should be possible to create
other nuclease-resistant sensors with aptamer recognition
domains that function under a wide range of natural conditions.
Mosaic Nucleic Acids
Motivated by a desire to understand chemical steps that led to
the emergence of early genetic systems, Szostak and coworkers
have demonstrated that nucleic acid molecules with heteroge-
neous backbones can evolve ligand-binding functions despite
the repeated shuffling of backbone chemistry between iterative
cycles of selection (Trevino et al., 2011). In a simplified model
system, a mutant T7 RNA polymerase (Y639F) capable of
transcribing nucleic acids that contain both deoxy- and ribonu-
cleotides was used to construct a library of oligonucleotides
that contained equal amounts of DNA and RNA residues. These
DNA-RNA chimeric polymers were given the name mosaic
nucleic acids (MNA). The library was used to isolate nucleo-
tide-binding MNA aptamers by in vitro selection. After each
round of selection, functional sequences were reverse-
transcribed into DNA and amplified by RT-PCR. The molecules
were then forward-transcribed back into MNA, which retained
the nucleotide sequence but randomized the sugar-phosphate
backbone. As a consequence, sequences that depended on
specific sugar arrangements were selected against, while
sequences that retained function despite variation at the sugar
positions were enriched. Following multiple rounds of selection
and amplification, MNA aptamers were identified from two
parallel selections that targeted ATP and GTP, respectively.
The selected aptamers bound specifically to their cognate
ligands, demonstrating that nonheritable backbones may not
have posed an insurmountable obstacle to the emergence of
early functional molecules. Whether similar selections could
yield MNA molecules with catalytic activity is an interesting
question that has yet to be determined.
XNA Polymers with Novel Backbone Structures
Peptide Nucleic Acid
One of the most interesting molecules developed as a nucleic
acid analog is peptide nucleic acid (PNA; Figure 3). Unlike all
DNA and RNA analogs described thus far, which have a sugar-
phosphate backbone, PNA has a backbone composed of
repeating N-(2-aminoethyl)-glycine units that are linked by
peptide bonds (Nielsen et al., 1991a). Since PNA has an
uncharged backbone, hybridization with DNA is stronger than
DNA/DNA hybridization due to the absence of electrostatic
repulsion. PNA is also more specific for a given target sequence
than DNA or RNA, as base pair mismatches are more destabiliz-
ing for PNA than a natural oligonucleotide of the same sequence
(Nielsen, 1995). These properties, coupled with enhanced
nuclease stability, make PNA a useful molecule for antisense
therapy (Demidov et al., 1994). Although PNA cannot easily cross
the cellularmembrane, conjugation of PNA antisense oligonucle-
otides to cell-penetrating peptides has been used successfullyChemistry & Biology 1to improve cellular delivery (Shiraishi and Nielsen, 2011; Wittung
et al., 1995).
Recognizing the potential that synthetic polymers could have
in expanding the functional utility of genetic polymers, Liu and
colleagues recently described an in vitro translation, selection,
and amplification system for PNA (Brudno et al., 2010). Since
PNA is not a substrate for any known polymerase, conditions
were developed that allowed for the nonenzymatic sequence-
specific oligomerization of tetramer and pentamer PNA building
blocks on DNA templates. These building blocks collectively
represent a ‘‘genetic code’’’ for PNA that can be faithfully ‘‘trans-
lated’’ on a DNA template using reductive amination chemistry to
link multiple PNA units together. For example, 10 consecutive
coupling reactions of pentamer codons lead to the synthesis of
a 50-mer PNA molecule containing secondary amine linkages
between every fifth nucleotide. Translation on a library of self-
priming DNA templates produced a pool of PNA-DNA hairpins
in which one strand was composed of PNA and the other strand
was composed of DNA. As illustrated in Figure 4, the DNA
portion of these molecules was then made double-stranded by
extending a DNA primer annealed to the stem-loop region of
the hairpin with dNTPs. This difficult step required Herculase II,
a strong thermophilic DNA polymerase to copy the DNA strand
by displacing the PNA strand. The resulting PNA-dsDNA mole-
cules contained the genotype-phenotype linkage necessary to
perform in vitro selection since the PNA molecules could be
selected on the basis of their chemical function and their encod-
ing DNA information could be amplified by their attached DNA
sequence. The authors validated this approach in a proof-of-
principle demonstration by performing six iterative cycles of
translation, selection, and amplification for PNA molecules that
could incorporate a biotinylated codon into their sequence.
The selection showed an overall enrichment of >106-fold of
PNA-encoding DNA templates on streptavidin-coated beads.
This example suggests that it should be possible to isolate
functional PNA aptamers by in vitro selection.
Threose Nucleic Acid
Among the many different alternative nucleic acid molecules
developed by Eschenmoser and colleagues, a-L-threose nucleic
acid (TNA) has emerged as the first genetic polymer with rele-
vance in synthetic genetics (Figure 3) (Scho¨ning et al., 2000).
TNA is an artificial nucleic acid polymer in which the natural
five-carbon ribose sugar found in RNA has been replaced with
an unnatural four-carbon threose sugar and phosphodiester9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1365
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Figure 4. In Vitro Selection Strategies for XNA Evolution
(A) DNA display provides a general strategy for evolving XNA polymers when an RT is not available to convert XNA sequences back into DNA for amplification by
PCR. In this technique, a genotype-phenotype link is established by extending a self-priming DNA library with XNA to link each XNAmolecule to its encoding DNA
sequence.
(B) When an XNA transcriptase and RT are available, in vitro selection can be performed using a traditional two-enzyme replication strategy.
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substitution shortens the backbone repeat unit by one bond as
compared to natural DNA and RNA. Eschenmoser found that
TNA undergoes informational Watson-Crick base pairing in an
antiparallel strand orientation and also cross-pairs opposite
complementary strands of DNA and RNA (Scho¨ning et al.,
2000). This latter feature is remarkable given the backbone
difference between TNA and the natural genetic polymers of
DNA and RNA.
The ability for TNA to exchange genetic information with RNA,
coupled with the chemical simplicity of threose relative to ribose,
have prompted careful consideration of TNA as a possible RNA
progenitor (Orgel, 2000). To explore this possibility, we and
others have attempted to identify polymerases that could be
used to examine the functional properties of TNA by in vitro
selection. Numerous primer-extension assays were performed
to identify DNA polymerases that could copy DNA templates
into TNA (Chaput and Szostak, 2003; Kempeneers et al., 2003)
and other polymerases that could copy TNA back into DNA
(Chaput et al., 2003). By identifying enzymes that could perform
these functions, we aimed to develop a replication system for
TNA that allowed pools of TNA molecules to be reverse-tran-
scribed into DNA, amplified by PCR, and forward-transcribed
back into TNA. From this body of work, it was discovered that
therminator DNA polymerase, an engineered variant of the 9 N
DNA polymerase bearing the A485L mutation functions as an
efficient DNA-dependent TNA polymerase (Horhota et al.,
2005; Ichida et al., 2005). Under optimal conditions, therminator
was found to copy a long DNA template into TNA with high effi-
ciency and fidelity but failed to copy a pool of DNA sequences
into TNA (Ichida et al., 2005). We subsequently determined
that stretches of G-nucleotides in the DNA template sequence
lead to polymerase pausing and chain termination. By designing
DNA libraries that either eliminated all G-residues in the template
or presented G nucleotides at sufficiently low frequency so they
would occur as isolated residues, we were able to efficiently
transcribe DNA libraries into TNA (Yu et al., 2012). Consequently,1366 Chemistry & Biology 19, November 21, 2012 ª2012 Elsevier Ltdthe resulting TNA sequences were either devoid of cytidine or
contained cytidine at reduced frequency.
To determine whether TNA could fold into structures with
discrete ligand-binding properties, a DNA display strategy
similar to the hairpin strategy developed by Liu and colleagues
was used to evolve TNA aptamers with affinity to human
thrombin (Figure 4) (Brudno et al., 2010). This approach provides
a solution to the problem of how to evolve XNA polymers when
an RT is not available to convert the pool of XNA molecules
back into DNA for amplification by PCR. Accordingly, a pool of
self-priming DNA templates was extended with TNA using ther-
minator DNA polymerase to copy the DNA library into TNA. The
DNA region of the TNA-DNA chimeric hairpins was made
double-stranded by extending a separate DNA primer annealed
to the step-loop structure with dNTPs. The resulting TNA-dsDNA
molecules produced the genotype-phenotype linkage necessary
to perform iterative rounds of in vitro selection and amplification
since TNA molecules could be selected on the basis of function
and amplified on the basis of their attached DNA sequence.
After several rounds of in vitro selection and amplification, TNA
aptamers emerged with high binding affinity and specificity to
human thrombin. The best aptamer identified in the selection
bound to thrombin with an equilibrium dissociation constant of
200 nM, which is similar to DNA and RNA aptamers previously
evolved to bind human thrombin. The isolation of TNA aptamers
from a pool of random TNAmolecules demonstrated, for the first
time, that the problem of ligand binding is not unique to the
natural polymers of RNA and DNA or close structural analogs
thereof (Yu et al., 2012). Indeed, one could imagine that purely
chemical constraints, like a shorter backbone repeat unit, might
preclude the ability for TNA to fold into structures with a desired
function. Since TNA does not appear to be limited in this regard,
it seems reasonable that similar selections for catalytic function
could be used to isolate novel TNA enzymes or ‘‘threozymes’’ by
in vitro evolution. As these studies progress, it will be interesting
to see how the functional properties of TNA compare to other
XNA molecules.All rights reserved
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Figure 5. Promising XNA Systems with Potential Application in Synthetic Genetics
The future of synthetic genetics will likely include a wide range of alternative genetic systems that are each capable of undergoing Darwinian evolution. These
examples highlight a few promising candidates for future XNA polymers.
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Hexitol nucleic acid (HNA) was the second XNA polymer to be
studied in the context of synthetic genetics (Figure 3) (Pinheiro
et al., 2012). Developed by Herdewijn and colleagues as an anti-
sense reagent (Verheggen et al., 1993, 1995), HNA has a back-
bone structure composed of 10,50-anhydrohexitol, which is
a six-membered pyranosyl ring structure. The nucleobase is
located at the 20 position and phosphodiester linkages occur
between the 40 and 60 carbon atoms. Unlike most other RNA
analogs with six-membered carbohydrate moieties (Herdewijn,
2010), such as homo-DNA and pyranosyl-RNA (Krishnamurthy
et al., 1996), HNA is capable of base pairing opposite comple-
mentary strands of itself and RNA and DNA (Hendrix et al.,
1997a, 1997b). The rigid anhydrohexitol ring adopts a chair
conformation that causes HNA to form an A-type helical struc-
ture (Declercq et al., 2002; Lescrinier et al., 2000; Maier et al.,
2005). Like PNA, HNA is also more specific for a given target
sequence than DNA or RNA and HNA is able to distinguish
base pair mismatches more easily than a natural oligonucleotide
of the same sequence (Hendrix et al., 1997b).
To explore the functional properties of HNA, Holliger and
coworkers used a compartmentalized self-tagging strategy to
evolve DNA polymerases capable of copying DNA templates
into HNA (Pinheiro et al., 2012). The authors constructed a
library of polymerase variants based on the DNA enzyme
Thermococcus gorgonarius (Tgo) polymerase by randomly
incorporating genetic mutations into the parent gene. The library
was then used to identify mutant polymerases capable of
synthesizing HNA polymers on DNA templates. The selection
produced several enzymes that exhibited broad substrate
specificity, including polymerases that could transcribe HNA,
cyclohexenyl nucleic acids, locked nucleic acids (Campbell
and Wengel, 2011), TNA, arabinose nucleic acid (Noronha
et al., 2000) and 20-fluoro arabinose nucleic acid (Wilds andChemistry & Biology 1Damha, 2000). To reverse-transcribe the XNA polymers back
into DNA, the authors evolved several novel RTs that could
copy HNA and other XNA polymers back into DNA. Their starting
library utilized statistical correlation analysis to identify an
allosteric network responsible for template recognition and
RNA-RT activity in the polB family of DNA polymerases. Neigh-
boring residues in the vicinity of possible hits were mutated
and screened in a polymerase activity assay. This approach
identified a new TgoTmutant, called RT521, that was a proficient
HNA RT. Together, the two enzymes allowed for the in vitro
evolution of HNA aptamers (Figure 4). HNA aptamers were
generated against HIV trans-activating response RNA and the
protein hen egg lysozyme. Both aptamers were found to bind
their targets with high affinity and specificity, consistent with
the interpretation that HNA, like TNA, can fold into shapes with
very specific ligand binding sites (Yu et al., 2012). Perhaps
even more importantly, however, the Holliger study provided
a general approach for creating XNA polymerases with broad
application in synthetic genetics.
Moving Beyond DNA and RNA: Implications for
Exobiology, Molecular Medicine, and Synthetic Biology
Armed with a new generation of polymerases and a large collec-
tion of nucleic acid modifications, the field of synthetic genetics
plans to expand the frontier of in vitro genetics to include
a growing list of structurally diverse XNA polymers (Figure 5).
Motivation for this work comes, in part, from a strong desire to
understand basic physical properties that may have contributed
to nature’s choice of ribofuranosyl nucleic acids (DNA and RNA)
as life’s genetic material (Eschenmoser, 1999). Since it is impos-
sible to rewind the evolutionary clock of time, experiments of this
type provide an important model for evaluating the fitness of
a given genetic polymer for a particular chemical function.
Although all forms of life (including those that are known to
have existed but are now extinct) are based on organisms that9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1367
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reactions with protein enzymes, earlier forms of life may have
relied on one biopolymer, not DNA or protein per se, but maybe
something else (Joyce, 2002). One possibility is that life evolved
from simple organisms that were based on RNA (Crick, 1968;
Orgel, 1968; Woese, 1967). This postulate, commonly referred
to as the RNA world hypothesis (Gilbert, 1986), received wide-
spread popularity following the discovery that RNA catalysts
exist in nature (Kruger et al., 1982). Since then,many other exam-
ples of RNA enzymes, or ribozymes, have been discovered and
others with functions more relevant to the RNA world have been
created by in vitro selection (Joyce, 2004; Wilson and Szostak,
1999). Despite these observations, it is difficult to envision how
a molecule as complicated as RNA could have emerged on the
early Earth and remained in the environment long enough to
replicate and produce offspring. This concern has led some to
suggest that RNA was not the first genetic material, but rather
an important evolutionary intermediate in the path to extant life
(Engelhart and Hud, 2010; Joyce et al., 1987).
If RNA was not the first genetic material, then what genetic
polymers came before RNA? Whatever prebiotic chemistry
gave rise to RNA would have almost certainly produced other
RNA analogs, some of which could have preceded or competed
directly with RNA. This hypothetical period in evolutionary history
is referred to as the pre-RNAworld—a timewhen chemistry gave
rise to simple self-replicating polymers that stored genetic infor-
mation and catalyzed chemical reactions (Lazcano and Miller,
1996). What these structures looked like and how they were
produced is a mystery that has challenged the minds of many
great chemists. Suggestions include PNAs (Nielsen et al.,
1991b), a class of RNA molecules with a protein-like backbone;
TNA (Scho¨ning et al., 2000), an unnatural genetic system with
a four-carbon threose sugar in place of the natural five-carbon
ribose sugar; and glycerol nucleic acid (GNA) (Zhang et al.,
2005), an acyclic derivative of TNA. These alternative genetic
systems are interesting because they are: (1) physically realistic,
meaning that they can be constructed by chemical synthesis; (2)
capable of storing genetic information via Watson-Crick base
pairing; and (3) chemically simpler than RNA,meaning that prebi-
otic chemistry could, in theory, have favored their synthesis over
RNA. With the advent of synthetic genetics, it should be possible
to evaluate the functional properties for at least a subset of
synthetic genetic polymers. Since some of these molecules are
also strong candidates for early RNA progenitors, these studies
provide abasis for comparingmolecular functions across a range
of biopolymer systems. As these studies progress, an important
goal will be to develop XNA enzymes that can catalyze their own
synthesis. If successful, these self-replicating molecules could
be used to develop synthetic life forms with unnatural genomes.
In addition to addressing basic questions related to life’s first
genetic system, synthetic genetics also provides an opportunity
to develop nuclease-resistant molecules for biotechnology and
molecular medicine. Nucleic acid molecules with specific target
recognition and catalytic properties have become valuable tools
in many areas of basic and applied research (Krishnan and
Simmel, 2011; Mascini et al., 2012; Tombelli and Mascini,
2009). Unfortunately, most of the molecules created thus far
are composed of DNA and RNA, which are susceptible to
nuclease degradation and therefore not suitable for most biolog-1368 Chemistry & Biology 19, November 21, 2012 ª2012 Elsevier Ltdical applications. In some cases, this problem can be overcome
by chemically modifying the nucleic acid backbone after the
selection is complete; however, structural changes of this type
are often expensive to implement and come with uncertain
outcomes. Synthetic genetics offers an alternative solution to
this problem by producing functional molecules with nucleic
acid backbones that are not recognized by natural enzymes.
This property of molecular invisibility represents a possible para-
digm shift, as functional molecules will now be cloaked behind
an unnatural nucleic acid backbone. Whether XNA polymers
will be able to supplant their DNA and RNA counterparts will
depend on how well these molecules function in biological envi-
ronments and the availability of XNA triphosphates and enzymes
needed to produce these molecules by in vitro selection.
Beyond therapeutic and diagnostic applications, synthetic
genetics could find widespread use in future synthetic biology
projects. Many practitioners of synthetic biology treat gene
networks found in living organisms as electronic circuitry that
can be ‘‘rewired’’ to produce engineered organisms with new
metabolic pathways embedded in their genomes (Benner and
Sismour, 2005). This process of reading and writing genetic
information relies on the fact that DNA is a universal language
recognized by all organisms. Consequently, synthetic biologists
often view DNA, as a plug-and-play technology where genetic
pathways are seamlessly transplanted from one organism into
another. Unfortunately, in practice, DNA does not always func-
tion in a predictable manner, and unexpected problems can
arise due to such genetic properties as epistasis and pleiotropy,
which occur when the effects of one gene are modified by other
genes or when a single gene exhibits multiple phenotypic traits,
respectively. Another disadvantage of using DNA is that safety
measures are difficult to engineer, as wild-type and engineered
genes cannot be distinguished by the cellular machinery respon-
sible for transcribing and translating genetic information. This
problem raises the concern that aberrant mutations in engi-
neered organisms could have unintended consequences that
are harmful to society if the organism escapes into the wild.
One way to mitigate the risks of bioengineering is to use genetic
polymers that are not recognized by natural enzymes (Herdewijn
and Marlie`re, 2009). Using this approach, engineered organisms
that escape into the wild would pose a minimal risk to society
because XNA substrates and XNA enzymes do not exist natu-
rally. In this light, XNA polymers represent an attractive genetic
material for synthetic biology as their molecular invisibility
provides the orthogonality needed to establish a genetic firewall
between nature and synthetic biology (Schmidt, 2010). Although
widespread use of synthetic genetic polymers may be years
away, the potential for XNA polymers to function as safe and
effective tools in synthetic biology warrants continued techno-
logical development.
Conclusions
The emerging field of synthetic genetics provides a rich opportu-
nity to explore the functional landscape of artificial genetic
polymers by in vitro evolution. Currently, the most promising
xenonucleic acids are TNA and HNA—two unnatural genetic
polymers capable of undergoing Darwinian evolution in the labo-
ratory. We anticipate that the continued development of nucleic
acid chemistry and molecular biology techniques will enable theAll rights reserved
Chemistry & Biology
Reviewcreation of additional examples of XNA polymers that exhibit
heredity and evolution (Deleavey and Damha, 2012; Herdewijn
and Marlie`re, 2012). Further pursuit of these polymers provides
an exciting opportunity to develop novel genetic polymers with
significant downstream applications in exobiology, molecular
medicine, and synthetic biology.ACKNOWLEDGMENTS
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